Brief: GeNeuro Reports Q1 Net Cash Position Of 11.8 Million Euros

Geneuro SA

27/04/2020 06:41

April 27 (Reuters) - Geneuro SA  GNRO.PA :
    * AT MARCH 31, 2020, GENEURO HAD EUR 11.8 MILLION IN CASH
    * COMPANY'S OPERATIONS FUNDED UNTIL MID-2022
    * NET CASH POSITION OF EUR 11.8 MILLION, FOLLOWING
SUCCESSFUL
CAPITAL INCREASE IN JANUARY 2020
    * TEMPORARY DELAY OF THE NEW CLINICAL TRIAL OF TEMELIMAB IN
MULTIPLE SCLEROSIS (MS) DUE TO COVID-19; RESULTS STILL EXPECTED
FOR 2021
    * APPOINTMENT OF MULTIPLE SCLEROSIS EXPERT PR. DAVID
LEPPERT, AS
CHIEF MEDICAL OFFICER
    * TEMPORARY DELAY OF NEW CLINICAL TRIAL OF TEMELIMAB IN
MULTIPLE
SCLEROSIS DUE TO COVID-19; RESULTS EXPECTED FOR 2021
    * ALL INVESTOR AND INDUSTRY EVENTS HAVE BEEN POSTPONED DUE
TO
COVID-19 PANDEMIC

Source text for Eikon:  ID:nBwbmnXc7a 
Further company coverage:  GNRO.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))